Descriptive features of the SLE–DLBCL (n=20) cohort
| Variable | Median (IQR) |
| Age of SLE diagnosis | 45 (36–54) |
| Age at time of DLBCL diagnosis | 58 (48–66) |
| SLE duration at DLBCL diagnosis | 11 (5–18)* |
| N (%) | |
| Sex (female) | 18 (90) |
| Diagnosed after 1991 | 12 (60) |
| Nodal-only involvement | 10 (50) |
| Extranodal-only involvement | 7 (35) |
| MYC-IHC positive | 6 (30) |
| BCL2-IHC positive | 8 (40) |
| BCL6-IHC positive | 7 (35) |
| Dual expressers* | 2 (10) |
| Non-germinal B-cell origin (Hans) | 12 (60) |
*Defined as expression of MYC and BCL2 by immunohistochemistry (IHC).
DLBCL, diffuse large B-cell lymphoma.